Risk stratification in men with a negative prostate biopsy: an interim analysis of a prospective cohort study.

BJU International
Mads SandahlKarina Dalsgaard Sørensen

Abstract

To investigate whether a risk score for prostate cancer (PCa) lifetime risk can be used to optimise triaging of patients with a negative prostate biopsy, but under sustained suspicion of PCa. In this prospective clinical study, we included, and risk scored patients who had a PCa-negative transrectal ultrasonography (TRUS)-guided prostate biopsy, but elevated prostate-specific antigen (PSA), a suspicious prostate digital rectal examination and/or a positive family history (FH) of PCa. The risk score estimated individual lifetime risk of PCa, based on a polygenic risk score (33 single nucleotide polymorphisms), age, and FH of PCa. Patients were followed, under urological supervision, for up to 4 years with annual controls, always including PSA measurements. Multiparametric magnetic resonance imaging (mpMRI) and/or prostate biopsy was performed at selected annual controls depending on risk score and at the urologist's/patient's discretion, which means that the follow-up differed based on the risk score. We included 429 patients. After risk scoring, 376/429 (88%) patients were allocated to a normal-risk group (<30% PCa lifetime risk) and 53/429 (12%) to a high-risk group (≥30% PCa lifetime risk). The high-risk group had significant...Continue Reading

References

Apr 1, 2003·The Journal of the American Board of Family Practice·Kishor Mistry, Greg Cable
Oct 18, 2005·BJU International·E David CrawfordPriya N Werahera
Nov 7, 2006·São Paulo Medical Journal = Revista Paulista De Medicina·Carlos Márcio Nóbrega de JesusCarlos Roberto Padovani
Jul 12, 2011·Nature Genetics·Zsofia Kote-JaraiUNKNOWN PRACTICAL Consortium
May 15, 2012·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Joseph H YacoubOto Aytekin
Jul 18, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ethan BaschRobert K Nam
Jul 20, 2012·The New England Journal of Medicine·Timothy J WiltUNKNOWN Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group
Aug 17, 2012·The New England Journal of Medicine·Eveline A M HeijnsdijkHarry J de Koning
May 28, 2013·International Journal of Molecular Sciences·Vicki M VelonasStephen J Assinder
Dec 4, 2013·Nature Reviews. Urology·Rosalind EelesZsofia Kote-Jarai
Sep 15, 2014·Nature Genetics·Ali Amin Al OlamaChristopher A Haiman
Oct 3, 2015·European Urology·Jeffrey C WeinrebSadna Verma
Dec 13, 2016·British Medical Bulletin·S Benafif, R Eeles
Feb 7, 2017·Clinical Laboratory·Zhi-Jun FengNan Zhang
Jun 5, 2017·The Medical Clinics of North America·Michael J Barry, Leigh H Simmons
Dec 21, 2017·Prostate Cancer and Prostatic Diseases·Tobias NordströmMartin Eklund
Jan 13, 2018·BMJ : British Medical Journal·Tyler M SeibertUNKNOWN PRACTICAL Consortium*
Mar 20, 2018·The New England Journal of Medicine·Veeru KasivisvanathanUNKNOWN PRECISION Study Group Collaborators
Jun 13, 2018·Nature Genetics·Fredrick R SchumacherUNKNOWN Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIP
Feb 19, 2019·Asian Journal of Urology·William B Isaacs, Jianfeng Xu
Nov 30, 2019·Cancer Treatment Reviews·Isabel HeideggerUNKNOWN EAU-YAU Prostate Cancer Working Party
Feb 17, 2021·BMC Medical Research Methodology·Martin Nygård JohansenErik Thorlund Parner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.